Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Condition:   Asthma Interventions:   Drug: ARS-1;   Drug: Albuterol MDI;   Drug: Placebo Sponsor:   ARS Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - May 6, 2022 Category: Research Source Type: clinical trials